August 26, 2008

 

Bioniche Immunotherapy now listed as "organic" for cattle use
   

 

Bioniche Life Sciences Inc. announced that its Bioniche Animal Health USA, Inc., has been granted full listing by the Organic Materials Review Institute (OMRI) for its premier immunostimulant technology for calves, Immunoboost.

 

The addition of Immunoboost to the official OMRI list indicates that this biological product has met the national standard for use in organic dairy and beef operations in the US.

 

Immunoboost is USDA-licensed for use in calves between the ages of one and five days, as a one-time immunotherapeutic treatment for reduction of the mortality and morbidities associated with calf scours caused by E. coli (K99) infections.

 

Immunoboost is a mycobacterial cell wall extract (MCWE) formulation. A distinct and more advanced Bioniche technology that also uses mycobacterial cell walls - Mycobacterial Cell Wall-DNA Complex (MCC) - is currently undergoing Phase III clinical testing in human patients with non-muscle-invasive bladder cancer in 31 North American urology centres.

 

Agriculture and Agri-Food Canada stated in a report that the natural beef market in the US is one of the fastest growing segments of the beef market, driven by healthier eating choices, food scares and health-related issues.

 

The US natural beef sector is estimated to be worth US$500 to US$550 million annually, or 1 percent of the total US beef market. Overall beef sales in the US have been slowing since peaking in the 1970's and overall beef production figures continue to decline. However, the natural beef sector is growing by roughly 20 percent annually.

 

The Organic Materials Review Institute (OMRI) is a national non-profit organization that determines which input products are allowed for use in organic production and processing. Only OMRI Listed products may be used on operations that are certified organic under the USDA National Organic Program.

 

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide.

Video >

Follow Us

FacebookTwitterLinkedIn